Benzinga··Vandana SinghEnsysce Biosciences Stock Jumps on Strategic Review Announcement
Ensysce Biosciences stock surges 58.66% after announcing a strategic review of partnerships, licensing, and asset sales to maximize shareholder value.
ENSCEnsysce Biosciencesstrategic review